Jane Whitrow

The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs.

Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco.

YFM Private Equity Ltd (YFM-PE) is a private equity specialist headquartered in Leeds, UK. YFM-PE, incorporated in 1987 as Mosspire Ltd., is a subsidiary of YFM Group Ltd., itself a subsidiary of Greater London Enterprise Ltd. in the UK. The firm manages private equity funds, while their sister company, YFM Venture Finance, focuses on earlier stage venture capital investments.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

PainePR, Inc. provides public relation services. It offers clients signature strategic services in national media relations, product and service marketing, corporate social responsibility, cause-related, hispanic marketing, crisis communications, organizational communications and change management services. The company was founded by David M. Paine in 1986 and is headquartered in Irvine, CA.

Vision RT Ltd. develops technology for radiation therapy. It offers AlingRT, GateCT, GateRT, SRS Module and third party interfacing. The firm provides solutions for the radiotherapy market, with products installed in some of the treatment centers. The company was founded by Ivan Daniel Meir, Peter Kalms, and Norman Ronald Smith in 2001 and is headquartered in London, the United Kingdom.

Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London.

Molecular Vision Ltd. develops low-cost, lab-quality, point of care, disposable diagnostic devices for medical testing. The company was founded by Donal D. C. Bradley in 2001 and is headquartered in York, the United Kingdom.

Golin Harris, Inc. provides content creation, digital strategy, and public relation services. The private company is based in Arlington, VA.

Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom.

Touchstone Innovations Businesses LLP commercializes academic research and technology businesses. The company was founded on December 19, 2007 and is headquartered in London, the United Kingdom.

MDX Medical, Inc. provides online doctor evaluation and comparison services. It offers health plans, employers vitalsmartshopper and consumer media kit. The company was founded by Mitchel E. Rothschild, Richard D. Forman and Todd K. Rosengart in 2006 and is headquartered in Lyndhurst, NJ.

Corob Consolidated Ltd. operates as a holding company with interest in investment services. The company was founded on March 6, 1984 and is headquartered in London, the United Kingdom.

Part of Corob Consolidated Ltd., Corob Holdings Ltd. provides property investment services. The company is based in London, UK.

Part of Corob Consolidated Ltd., Corob Retail Investments Ltd. is a British company that provides real estate investment services. The company is based in London, UK and was founded in 1992.

Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom.

Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom.

Crowdcube Ltd. provides an investment crowd funding platform. The firm's platform allows entrepreneurs to rise funding from their own network of friends, family, customers and strangers. The company was founded by Darren Westlake and Luke James Lang in 2010 and is headquartered in Exeter, The United Kingdom.

Topivert Pharma Ltd. is a British pharmaceutical company founded in 2011. The private company develops non-systemic medicines for the treatment of chronic inflammatory diseases of the gastrointestinal.

Kesios Therapeutics Ltd. provides biotechnology services. It develops novel therapeutics for the treatment of multiple myeloma and other cancers where there are significant unmet medical needs. The company was founded by Menotti Ruvo, Laura Tornatore, and Guido Franzoso on July 13, 2012 and is headquartered in Cambridge, the United Kingdom.

ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.

Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom.

Myricx Pharma Ltd. engages in the development of novel proprietary inhibitors of human N-myristoyltransferases. The company was founded by Ed Tate, Roberto Solari, and Andrew Bell in 2019 and is headquartered in Stevenage, the United Kingdom.

Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware.